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INTRODUCTION
Facultatively anaerobic Gram-negative bacteria including Escherichia coli and Salmonella
enterica serovar Typhimurium contain the isoprenoid quinones of the benzene and
naphthalene series. The structures of these quinones are shown in Fig. 1. According to the
IUPAC-IUB recommendations (65), the benzoquinones are termed ubiquinones (Q-n)
(structure I in Fig. 1) and the naphthoquinones are termed either menaquinones (MK-n)
(structure II in Fig. 1) or demethylmenaquinones (DMK-n) (structure III in Fig. 1). The n
refers to the number of prenyl units present in the side chain. It should be pointed out that
while MK is considered a vitamin (vitamin K2), Q is not, due to the fact that vitamin-K is an
essential nutrient (can not be synthesized) by mammals, while Q is not an essential nutrient
since it can be synthesized from the aromatic amino acid tyrosine.
The major quinones in E. coli are Q-8, MK-8, and DMK-8; minor amounts of Q-1 to Q-7,
Q-9 and MK-6, MK-7, MK-9, and DMK-7 may also be present (23). The prenyl side chains
have all-trans configuration (9). In contrast to the extensive investigations on the quinone
composition and biosynthesis in E. coli, S. enterica has been studied to a lesser extent. These
organisms neither have quinones that have one or more of the prenyl residues of the side
chain reduced nor MK with more than one methyl group. Methods for the extraction,
purification, identification and analysis of the quinones have been reviewed extensively (9,
22, 27, 33, 46, 59, 83, 85, 96, 100–102, 113, 127, 128, 130, 144, 157, 160, 170).
Since the last edition of E. coli/Salmonella, the following reviews on the subject have
appeared. Reviews on the reaction mechanisms of various enzymes involved in MK and Q
biosynthetic pathways have been published by Begley (6) and Meganathan (103). Two short
reviews on Q biosynthesis have appeared (107, 152). In most of these reviews, the work on
E. coli and to a lesser extent on Salmonella predominated due to the ease with which these
organisms can be manipulated. However, due to advances in technology, it has become a
reality that work on other bacteria can be carried out with ease.
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Hence, driven by economic and chemotherapeutic potential, research in certain aspects of
the MK and Q biosynthesis in some organisms has moved ahead of that of E. coli. The MK
and the phylloquinone biosynthetic pathways (the reactions of biosynthesis are identical
except the prenylation) are unique to bacteria and plants respectively and are absent in
humans and animals. Hence, there is great commercial interest in discovering chemicals that
will inhibit the enzymes of the pathway. Such chemicals will be of use as herbicides and
chemotherapeutic agents against pathogens such as multi drug resistant Mycobacterium
tuberculosis and Methicillin-resistant Staphylococcus aureus (MRSA). With the idea of
designing drugs, the crystal structure of MenB from M. tuberculosis has been solved by two
different groups (70, 161) and that of S. aureus was recently reported (163). Hence in this
review whenever there is work on organisms that is not available in E. coli it will be
included. It is expected that the crystal structures of enzymes will be similar if not identical
in most organisms since they perform chemically identical reactions.
Most of the information concerning the biosynthesis of MK and Q was obtained with E. coli
by using isotopic tracers, by the isolation of mutants, and accumulation of intermediates and
enzyme assays. Due to space limitations, only a general account is given here; for more
information, several comprehensive reviews should be consulted (7, 8, 10, 12, 13, 53, 54,
163, 168). Both MK and Q are derived from the shikimate pathway and as such have some
common structural features. The quinone nucleus of Q is derived directly from chorismate
while that of MK is from isochorismate via chorismate. The prenyl side chain on the nucleus
of both is derived from prenyl PPi and the methyl groups are derived from S-
adenosylmethionine. In addition, MK biosynthesis requires 2-ketoglutarate and thiamine
PPi, coenzyme A and ATP as cofactors. The biosynthesis of Q under aerobic conditions has
the additional requirements for oxygen, flavoprotein, and NADH. Finally, it should be noted
that the Q biosynthetic pathway in prokaryotes differs in several respects from that of
eukaryotes (71, 103, 107, 122, 152).
In spite of the fact that both quinones originate from the shikimate pathway, there are
several important differences.
1. In the formation of the quinoid nuclei, the pathway for Q diverges at chorismate
with the loss of a pyruvoyl group, due to the action of chorismate lyase, resulting in
the formation of a benzenoid aromatic acid which is used as the framework on
which the rest of the molecule is constructed. MK biosynthesis diverges at
isochorismate by the addition of succinic semialdehyde-TPP anion derived from 2-
ketoglutarate resulting in the formation of 2-succinyl-5-enolpyruvyl-6-hydroxy-3-
cyclohexene-1-carboxylic acid (SEPHCHC). In the subsequent reaction, the
pyruvoyl group is eliminated resulting in the prearomatic compound 2-succinyl-6-
hydroxy-2,4-cyclohexadiene-1-carboxylic acid (SHCHC). This is then aromatized
to a benzenoid aromatic acid and used as the framework for the construction of the
rest of the molecule as shown in Fig. 2.
2. In Q biosynthesis, the prenyl side chain is introduced at an early stage (second step)
with the retention of the aromatic carboxyl group. Conversely, while in MK
biosynthesis, prenylation is the next to last step and is accompanied by a
decarboxylation.
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3. In MK biosynthesis all the enzymes in the pathway up to the prenylation are
soluble (next to the last step). In Q biosynthesis the enzymes are membrane bound
except for the first enzyme.
4. In MK biosynthesis, methylation of the carbon of the nucleus is the last step while
the terminal step of Q biosynthesis is the methylation of a hydroxyl group. In
addition, in Q biosynthesis a second O-methylation and C-methylation take place in
the middle portion of the pathway. Surprisingly, both the C-methylation involved in
MK biosynthesis and the C-methylation in Q biosynthesis are carried out by the
same C-methyltransferase.
5. Q biosynthesis under aerobic conditions requires the introduction of OH groups by
reactions involving oxygen; anaerobic Q and MK biosynthesis utilize oxygen
atoms derived from water.
MK BIOSYNTHESIS
The MK biosynthetic pathway has been elucidated on the basis of tracer experiments,
isolation of mutants blocked in the various steps, isolation and identification of
intermediates accumulated by the mutants and by enzyme assays. Early isotopic tracer
experiments with various bacteria established that methionine and prenyl PPi contribute to
the methyl and prenyl substituents of the naphthoquinone. The early isotopic tracer studies
and other work have been reviewed by Bentley and Meganathan (12). In 1964, Cox and
Gibson observed that [G-14C] shikimate was incorporated into both menaquinone and
ubiquinone by E. coli, thus providing the first evidence for the involvement of the shikimate
pathway (25). Chemical degradation of the labelled isolated menaquinone (MK-8) showed
that essentially all of the radioactivity was retained in the phthalic anhydride. It was
concluded that "the benzene ring of the naphthoquinone (sic) portion of vitamin-K2 arises
from shikimate in E. coli"; (25). The authors further suggested that shikimate was first
converted to chorismate before incorporation into MK. A more complete chemical
degradation of the menaquinone derived from labelled shikimate established that all seven
carbon atoms were incorporated (18). The remaining three carbon atoms of the
naphthoquinone ring were shown to be derived from the middle three carbons of 2-
ketoglutarate with the loss of both carboxyl groups (17, 132, 133).
These studies established the immediate precursors of menaquinone as shikimate and the
noncarboxyl carbon atoms of 2-ketoglutarate forming the naphthoquinone nucleus. The
methyl and isoprenoid side chains were also shown to be derived from S-
adenosylmethionine and an isoprenyl alcohol pyrophosphate ester, respectively.
Subsequently it was shown that the benzenoid aromatic compound o-succinylbenzoate
(OSB) (29) and the naphthalenoid aromatic compound 1,4-dihydroxy-2-naphthoate (DHNA)
(12, 134) were incorporated into the naphthoquinone ring of menaquinone. This work was
confirmed by the demonstration that menB and menA mutants of E. coli excrete OSB and
DHNA, respectively, into the culture medium (173). During a study of the biosynthesis of
OSB by growing cultures of E. coli menB it was demonstrated that carbon atom one of the
glutamate (2-ketoglutarate) was lost and consequently not incorporated into OSB (108). The
isotopic labeling pattern is summarized in Fig. 3.
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Formation of isochorismate (Compound IV -------> V)
The first synthesis of OSB (IX), from chorismate (IV) and 2-ketoglutarate in the presence of
TPP by cell-free extracts of E. coli was obtained by Meganathan (105) (Fig. 4). However, it
had been suggested that isochorismate (V) was a much more attractive precursor than
chorismate on chemical grounds (29, 53). Evidence in support of this hypothesis was
provided (11, 36, 167).
Isochorismate is a common intermediate in the biosynthesis of the siderophore enterobactin
and MK. The conversion of chorismate to isochorismate in enterobactin biosynthesis is
mediated by the enzyme isochorismate synthase encoded by the entC gene (119, 162). The
dual role of isochorismate led to the question as to whether the entC encoded isochorismate
synthase (EntC) was supplying the isochorismate required for both pathways. Kaiser and
Leistner (72) reported the isolation of a Tn10 insertion in the entC gene that had lost
simultaneously the ability to form enterobactin and MK. It is generally accepted that the
entC gene is derepressed under iron deficiency and repressed under iron sufficiency (47,
116). Enterobactin is required only under aerobic conditions due to the poor solubility and
the consequent unavailability of iron in the Fe3+ form. When E. coli is grown anaerobically,
iron is present in the highly soluble Fe2+ form. Hence, the synthesis of enterobactin is
unnecessary for the acquisition of iron by the cell under anaerobic conditions (47, 116).
In contrast, MK is required under anaerobic conditions (12). Further, when the organism is
grown with fumarate, trimethylamine-N-oxide (TMAO) or dimethylsulfoxide (DMSO) as
electron acceptor, the presence of MK is obligatory (12, 48, 106, 112). When oxygen or
nitrate are the electron acceptors, the aerobic quinone, ubiquinone is used by E. coli (84).
Thus, while the conditions that favor the biosynthesis and function of Q are compatible with
the biosynthesis of enterobactin, they are incompatible with the biosynthesis of MK.
These apparent contradictions raised some intriguing questions. How does E. coli, growing
aerobically under iron deficiency when entC is fully derepressed, prevent the synthesis of
MK? Further, under anaerobic conditions, how does E. coli prevent the synthesis of
enterobactin when MK synthesis is induced? This paradox might be resolved if the entC
gene is regulated by iron in the presence of oxygen and by MK requirement in the absence
of oxygen. To study the regulation of the entC gene, an entC-lacZ operon fusion was
constructed and the expression of β-galactosidase monitored under various conditions. It was
found that the β-galactosidase was fully derepressed at low concentration of iron and
repressed at high iron concentrations under both aerobic and anaerobic growth conditions
(91, 93).
These results raised the question as to how E. coli is able to synthesize MK anaerobically
when growing in the presence of high concentrations of iron? How does the organism
prevent the excess production of MK under iron deficient aerobic conditions when entC is
fully derepressed? To answer these questions, anaerobic growth of an entC::Tn5 mutant was
tested on glycerol medium with TMAO, DMSO or fumarate as electron acceptors. The
mutant was able to grow at the same rate as the parent, even in the presence of high
concentrations of iron. Further, the mutant produced as much MK as the parent (91, 93,
104). These results provided clear evidence for the presence of an alternate isochorismate
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synthase specifically involved in MK biosynthesis. As a first step in locating and identifying
the gene encoding this alternate isochorismate synthase involved in MK biosynthesis,
further sequencing upstream of the 5′ region of the menD gene was carried out. An open
reading frame encoding a 430 amino acid protein exhibiting about 20% amino acid identity
with EntC was identified as MenF (30, 31, 91).
The isochorismate synthase (MenF) encoded by the menF gene has been overexpressed and
purified to homogeneity. The purified enzyme had a relative Mr of 48, 000 (30, 31) as
determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The native Mr, as
determined by gel filtration chromatography, was 98, 000, thus establishing that the native
enzyme is a homodimer (30). The enzyme showed a requirement for Mg2+ for maximal
activity.
It is expected that the origin of the hydroxyl groups and the mechanism of the reaction of
MenF and EntC will be identical. Four different mechanisms were proposed for the EntC
enzyme (165). The origin of the hydroxyl could be from three possible sources: 1).
molecular oxygen, 2). intramolecular transfer of the hydroxyl, or 3). from the solvent H2O.
While the incorporation of molecular oxygen is possible only in the case of aerobic
organisms intramolecular transfer or the incorporation of hydroxyl from water can be carried
out by both aerobes and anaerobes. Due to the reported absolute requirement of enterobactin
for the chelation of iron during aerobic growth under iron deficiency (47, 116) one would
expect the incorporation of molecular oxygen into the hydroxyl group. However, the
absence of redox cofactor rules out the involvement of oxygen and evidence has been
obtained demonstrating the incorporation of the C-6 hydroxyl from the solvent H2O for
EntC (165). Consistent with this result is the demonstration of anaerobic biosynthesis of
enterobactin in E. coli (91).
Recently, the 3D structure of MenF has been determined and the catalytic mechanism
probed by site directed mutagenesis and biochemical studies (80). Lys 190 has been
identified as the active site base that assists in the attack by water at the C2 carbon. An SN2"
reaction results in the rearrangement of 1–2, 5–6 double bonds resulting in the elimination of
the C4 hydroxyl group (80). These findings are in complete agreement with a common
mechanism proposed for the three chorismate-utilizing enzymes, anthranilate synthase (AS),
4-amino-4-deoxychorismate synthase (ADCS) and isochorismate synthase (IS) by He et al
(55).
Formation of succinic semialdehyde-TPP (SS-TPP) anion and Michael addition to
isochorismate (compound VI+V------>VIII)
During the studies on the biosynthesis of o-succinylbenzoate (OSB) (IX), cell extracts of
two groups of mutants designated as menC and menD blocked in the formation of OSB and
requiring OSB for anaerobic growth on glycerol-fumarate medium were examined. Cell
extracts of either mutant alone did not form OSB from chorismate (IV) and 2-ketoglutarate
in the presence of thiamin pyrophosphate. However, extracts from both mutants in
combination produced OSB, and extracts of menC mutants accumulated an intermediate,
which was converted to OSB by extracts of menD mutants (110). The intermediate was
found to be unstable, and on mild acid treatment yielded OSB and succinylbenzene. On the
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basis of these properties and nuclear magnetic resonance data, the intermediate was
identified as 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate (SHCHC) (VIII) (36).
It has been postulated that the 2-ketoglutarate undergoes a TPP-dependent decarboxylation,
with the formation of succinic semialdehyde anion of TPP (VI) (17, 105) and a requirement
for TPP in the reaction was shown (110). The mechanism of decarboxylation is identical to
that catalyzed by the first enzyme of the 2-ketoglutarate dehydrogenase complex (KGDH
complex) (Fig. 5)(11, 99). Using a sucA mutant, (which lacks the first enzyme of the KGDH
complex), and by selective removal of the KGDH complex it was established that the 2-
ketoglutarate decarboxylase (KDC) involved in OSB synthesis is a separate enzyme (13, 99,
167).
Subsequent studies established that the succinic semialdehyde anion (VI) of TPP reacted
with isochorismate (V) resulting in the formation of SHCHC (VIII) (11, 36, 167) as had
been postulated previously (29, 53). A mechanism for this reaction has been proposed (Fig.
5) (10, 11, 103). When the complete nucleotide sequence of the menD gene was determined
it was discovered that both SHCHC synthase and KDC activities are encoded by a single
gene (120). This conclusion was further strengthened by overexpression and purification of
the MenD protein and by showing that both activities co-purified during various steps of the
purification process (14, 89).
However, recently, Guo and colleagues have shown that the formation of SHCHC from
isochorismate and 2-ketoglutarate is a two step process requiring two different enzymes. The
first enzyme MenD decarboxylates the 2-ketoglutarate and adds the resulting succinic
semialdehyde anion of TPP (VI) to isochorismate (V) resulting in the formation of 2-
succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate (SEPHCHC) (VII) (67).
The mechanism of formation of succinic semialdehyde anion of TPP and its addition to
isochorismate is shown in Fig. 5. The stereochemistry of SEPHCHC was determined and
shown to be (1R, 2S, 5S, 6S)-2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1--
carboxylic acid (68). On the basis of these results, MenD was designated as SEPHCHC
synthase (67).
SEPHCHC is an unstable compound which, in mildly basic solutions, spontaneously
undergoes a 2, 5 elimination reaction resulting in the formation SHCHC and pyruvate.
Crystallization and a preliminary X-ray analysis of MenD has been reported (148)
The in vivo conversion of SEPHCHC to SHCHC (compound VII to VIII) is carried out by
(1R, 6R)-2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate (SHCHC) synthase
encoded by the menH gene (Fig. 4 and 5). Surprisingly, MenH contains a Ser-His-Asp
catalytic triad, which is typical of many proteases. This triad plays a critical role in enzyme
activity since replacing any one of the three amino acids by alanine results in a dramatic
decrease in catalytic activity (69). The structure of MenH from the enteric pathogen Vibrio
cholerae has been determined (Pdb# IR3D).
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The aromatization of SHCHC----->OSB (Compound VIII-------->IX)
Enzymatic removal of the elements of water from SHCHC (VIII) leads to the formation of
the benzenoid aromatic compound OSB (IX) (Fig. 4). The first evidence for the presence of
such an enzyme was obtained by the demonstration that cell free extracts of a menD mutant
converted SHCHC (designated as “X” at the time) to OSB (110). This enzyme was
subsequently designated as OSB synthase (126, 141). The gene encoding OSB synthase was
cloned and its complete nucleotide sequence reported (141).
The enzyme was overexpressed, purified to homogeneity and its properties investigated. The
enzyme required a divalent metal ion for activity like the other members of the enolase
superfamily. The enzyme was shown to carry out the dehydration of SHCHC to OSB very
efficiently with Kcat of (19±1s−1) and a Kcat/Km of (1.6 ±0.3×106M−1s−1) (121). OSB
synthase was classified as a member of the enolase superfamily. Members of this
superfamily carry out reactions initiated by abstraction of the α-proton from a carboxylate
anion substrate to generate a stabilized enolate anion intermediate (3). As pointed out above,
the reaction catalyzed by OSB synthase is a dehydration. It was proposed that the α-proton
of the carboxylate substrate (SHCHC) is likely abstracted by a basic catalyst (one lysine)
followed by the elimination of the β-hydroxyl group presumably by the assistance of an acid
catalyst (a second lysine) (121).
The structure of OSB synthase from E. coli in complex with Mg2+ and o-succinylbenzoate
was determined. It was found that OSB synthase is the only monomeric member of the
enolase superfamily. The product OSB was found to be sandwiched between Lys 133 and
Lys 235 located at the ends of the second and sixth β-strands. In addition, one carboxylate
oxygen of the substrate is coordinated to the Mg2+ (159). Subsequently, the structure of
OSB synthase from an inactive K133R mutant in complex with the substrate SHCHC was
determined. It was found that Lys 133 is the single base/acid catalyst for the dehydration
with the transient Mg2+ coordinated enolate anion intermediate. The dehydration was shown
to follow a syn-stereochemical course (74). The mechanism and specificity of various
members of the enolase superfamily including OSB synthase have been reviewed and
should be consulted for further details of the reaction mechanism (42).
Cyclization of OSB to DHNA (Compound IX ---------> XII)
The conversion of the benzenoid aromatic compound OSB (IX) to the naphthalenoid
aromatic compound 1,4-dihydroxy-2-naphthoate (DHNA) (XII), was demonstrated by
Bryant and Bentley (16). The process showed an absolute requirement for ATP and CoA.
Hence, OSB-CoA (X) was suggested as an intermediate. Using extracts of Mycobacterium
phlei, evidence was obtained for the presence of two enzymatic activities (OSB-CoA
synthetase and DHNA synthase). The OSB-CoA was found to be an unstable intermediate,
which spontaneously hydrolyzed to the spirodilactone form of OSB (Fig. 6, compound
XIX). Further, it was shown that during the formation of OSB-CoA, ATP was hydrolyzed to
AMP and PPi, which is typical of ligases forming CoA esters (109).
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The CoA moiety was suggested to be on the aromatic carboxyl group (16, 109) and evidence
in support of this suggestion was obtained (56, 57). However, in subsequent publications, it
was reported that the CoA is located on the aliphatic carboxyl group (81, 82).
A group of E. coli mutants responding to DHNA (XII), but not to OSB (IX) for anaerobic
growth on glycerol-fumarate medium was analyzed for their ability to convert OSB to
DHNA (143). None of the mutant extracts formed DHNA. However, when the cell extracts
from different mutants were mixed with each other, one of the mutant extracts
complemented with extracts of each one of the other three mutants and formed DHNA. To
identify the nature of the enzymatic defect in these mutants, cell extracts from each one of
these mutants were complemented with OSB-CoA synthetase and DHNA synthase from M.
phlei described above, and assayed for DHNA formation. The single mutant whose extract
was complemented by OSB-CoA synthetase, and therefore, lacking this enzyme was
designated as menE. The other three mutants, whose extracts were complemented by DHNA
synthase were designated as menB (143).
The menE gene was cloned and sequenced (140). The gene was overexpressed and the
enzyme purified to homogeneity. The purified enzyme had subunits of Mr 49,000 and a
native Mr of 185,000. Thus, the native enzyme appears to be a homotetramer. The Km values
for OSB, ATP and CoA were 16, 73.5, and 360 µM, respectively (88). By chemical
inactivation and site directed mutagenesis studies, an essential histidine residue (His341)
located in the ATP binding region has been identified as necessary for catalytic activity of
the enzyme (15). Sequence analysis combined with the fact that OSB-CoA synthetase
hydrolyses ATP to AMP and PPi and requires CoASH for the reaction earns it membership
in the acyl-adenylate/thioester forming superfamily of enzymes (19, 20). A mechanism for
the reaction has been proposed (Fig. 6).
The menB gene was cloned and its complete nucleotide sequence determined (142). When
the gene was overexpressed and the protein purified to homogeneity, the subunits were
found to have a Mr of 32,000, while the native protein had a Mr 112,000 as determined by
gel filtration. Thus, the enzyme is a homotetramer (103).
As discussed above, the substrate for MenB, OSB-CoA is highly unstable. Hence, for the
assay of MenB, the required OSB-CoA is generated in vitro by coupling the reaction with
the MenE reaction (12, 109). However, for the coupled assays, crude cell-free extracts were
always used. Surprisingly, when the overexpressed and purified MenE and MenB enzymes
were used in the coupled assay, DHNA formation was not observed. In order to determine
the reasons for the lack of formation of DHNA, small amounts of a crude cell-free extract of
E. coli were added to the reaction mixture, and this resulted in the restoration of activity in
the incubation mixture. Hence it appeared that either a cofactor or another protein might be
involved in the reaction.
On the basis of alignment and analysis of the sequence MenB was included in the enoyl-
CoA hydratase/isomerase (crotonase) superfamily (172). The failure of the purified MenB to
form DHNA in the complementation assay discussed above and its membership in the
enoyl-CoA hydratase superfamily (where other members form CoA esters) it was suggested
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that the product of MenB is DHNA-CoA (XI) rather than DHNA (XII) (103). Evidence in
support of this prediction has been obtained in Mycobacterium tuberculosis where the
product of MenB was identified by mass spectrometry as DHNA-CoA (XI) (161). The
crystal structure of MenB as the native enzyme and in complex with acetoacetyl-CoA and
DHNA-CoA respectively has been reported by Truglio et al. (161) and Johnston et al. (70).
The highly conserved active site of MenB contained a deep pocket lined with Asp-192,
Tyr-287 and hydrophobic amino acids. Site directed mutagenesis studies have established
that Asp-192 and Tyr-287 are essential for enzymatic catalysis. On the basis of structural
and mutagenesis studies, the authors have proposed a possible mechanism for cyclization of
OSB-CoA to DHNA-CoA (161).
On the basis of amino acid sequence homology to thioesterases, an unidentified orf152
(yfbB) was postulated to carry out the conversion of DHNA-CoA → DHNA and designated
as menH (103, 121). Evidence in support of the proposal was provided by experimental
demonstration of thioesterase activity of the protein (86).
However, as discussed above (section ___), the MenH protein has been unequivocally
demonstrated to carry out the conversion of newly discovered intermediate SEPHCHC to
SHCHC and has been christened as SHCHC synthase (69). Thus, the enzyme responsible for
the conversion of DHNA-CoA to DHNA remains to be identified.
Prenylation of DHNA to DMK (Compound XII-------->III)
The conversion of DHNA (XII) to DMK (III) in extracts of E. coli, was shown by Bentley
(8). Shineberg and Young (146) were able to isolate a membrane-bound 1,4-dihydroxy-2-
octaprenyltransferase. The menA gene encoding the enzyme has been cloned (155). The
enzyme (MenA) has many features in common with 4-hydroxybenzoate
octaprenyltransferase (UbiA) involved in the biosynthesis of ubiquinone. The two enzymes
share a common pool of membrane bound octaprenyl diphosphate (146). The conversion of
DHNA to DMK requires replacement of the carboxyl with the isoprenoid side chain.
Prenylation and decarboxylation may occur in a single active site, since symmetry
experiments exclude 1,4-naphthoquinone as an intermediate (4). Moreover, there has been
no evidence for two separate reaction steps or enzymes. A carbocation mechanism based on
the dimethylallyl tryptophan synthase reaction (40) has been proposed for the reaction (103).
In addition, a quinol to quinone oxidation is required in which demethylmenaquinol is a
likely intermediate; the oxidation to DMK is thought to be spontaneous.
Methylation of DMK to MK (Compound III--------->II)
DMK (III) is methylated to MK (II) by a methyltransferase, which uses S-
adenosylmethionine as the methyl donor. In experiments with whole cells it was shown that
all three hydrogen atoms of the methyl group of methionine are transferred to DMK (66).
The conversion of DMK-3 to MK-3 was demonstrated in cell extracts using S-[14CH3]-
adenosyl-L-methionine by Bryant and Bentley(16). An ubiA mutant of E. coli was found to
accumulate DMK but not MK. This mutant is believed to be defective in methylation of
DMK to MK, suggesting that this is a double mutant (35). In a subsequent study, it was
shown that an ubiE mutant, blocked in the methylation of the ubiquinone biosynthetic
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intermediate, 2-octaprenyl-6-methoxy-1,4-benzoquinol (OMB) (XXV) to 2-octaprenyl-3-
methyl-6-methoxy-1,4-benzoquinol (OMMB) (XXVI) (174) accumulated DMK but not MK
(171). Consistent with this observation is the simultaneous loss of C-methyltranferase
activity towards both OMB and DMK and its restoration by a plasmid containing the ubiE
gene (95, 171).
Q BIOSYNTHESIS
The ubiquinone biosynthetic pathway was elucidated largely due to the work of Gibson,
Cox, Young and colleagues (45, 46). In 1964, it was observed by Cox and Gibson that
[G-14C]-shikimate was incorporated into ubiquinone, thus establishing that the quinone was
derived from the shikimate pathway (25). Gibson and colleagues reasoned that since
ubiquinone is required for aerobic electron transport, mutants deficient in its biosynthesis
would grow fermentatively on glucose, but not aerobically on oxidizable substrates such as
malate or succinate, as the sole source of carbon and energy. Mutagenized cultures were
screened for the desired phenotype and potential mutants were analyzed for the presence or
absence of ubiquinone (45). Using this procedure, a number of mutants were isolated and it
was found that these mutants accumulated sufficient amounts of intermediates so that their
structure could be determined by mass spectrometry and magnetic resonance spectrometry
(45, 154).
The biosynthesis of the quinonoid ring and the various ring modification reactions in E. coli
have been reviewed (71, 73, 104, 152). A mechanistic perspective on the various reactions
has been provided (6, 103). As pointed out in the introduction, in E. coli and Salmonella, the
first committed step in the biosynthesis of Q is the formation of 4-hydroxybenzoate from
chorismate by the cytoplasmic enzyme chorismate lyase. The 4-hydroxybenzoate formed is
attached to the membrane bound octaprenyl diphosphate by a membrane bound
octaprenyltransferase. For the subsequent reactions, all the substrates and enzymes are in a
membrane bound complex. In this chapter, the intermediates, genes and enzymes involved
in the various reactions are presented first. This will be followed by a brief description of the
membrane bound multienzyme complex and the reported interactions of certain enzymes in
the complex with each other.
Conversion of chorismate to 4-hydroxybenzoate (Compound IV--------->XX)
The elimination of pyruvate from chorismate (IV), results in the formation of 4-
hydroxybenzoate (4-HB) (XX) (Fig. 7). This aromatizing reaction is the first committed step
in the biosynthesis of Q and is catalyzed by the enzyme, chorismate lyase, encoded by the
ubiC gene (94). The ubiC gene has been cloned; the enzyme was overexpressed and purified
to homogeneity. The UbiC is a monomer of 165 amino acids from which the N-terminal
methionine is post-translationally removed resulting in the functional enzyme. The enzyme
has a molecular weight of 18.645 Da and functions as a monomer. The Km was reported to
be around 6–10 µM (117, 147). The purified enzyme failed to accept isochorismate as a
substrate, but did convert 4-amino-4-deoxychorismate to 4-aminobenzoate (117). Thus, it
appears that the enzyme is unable to distinguish between the hydroxyl group and the amino
group at the C-4 position. Walsh et al. (165) have proposed a 1,2-elimination of the
elements of pyruvate for the aromatization similar to that of anthranilate synthase reaction.
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The C-4 H of chorismate is abstracted by the enzyme and loss of the C-3-enolpyruvyl group
then results in the formation of the 4-hydroxybenzoate (4-HB). It has been reported that the
enzyme was inhibited by 4-HB but not pyruvate (147). In a subsequent study, Holden et al.
circumvented the rapid influence of product inhibition on the initial reaction rate by using
progress curve analysis of stopped-flow kinetic measurements. Under these conditions the
Km increased by about 3-fold to 29 µM (60). The enzyme releases the pyruvate quickly and
retains the 4-HB with a 10-fold higher affinity (Kp = 2.1 µM) (39).
The crystal structure of UbiC protein has been solved. The wild type enzyme tended to
aggregate and precipitate even in the presence of reducing agents and salt. To circumvent
this problem, two surface-accessible cysteines at sequence positions 14 and 81 were
converted by site directed mutagenesis into serine. This mutant enzyme C14S/C81S,
designated as CCSS, showed greatly improved solubility and stability with minimal effect
on the catalytic properties (60). The crystal structure of the enzyme from the double mutant
at 1.4-Å and the wild-type enzyme at 2.0-Å in complex with the product, 4-HB was
determined. The core of the chorismate lyase consisted of 6-stranded antiparallel β-sheet
without spanning helices and novel connectivity. The product, 4-HB was shown to be bound
in an internal cavity behind two flaps which completely covers and shields the product from
the solvent. Three hydrogen bonds link the product to the internally charged side chains of
Arg76 and Glu155 and two additional hydrogen bonds link it to the flap atoms 34 N and
114N. These five hydrogen bonds play a direct role in binding the product. There are three
additional hydrogen bonds that link the flaps together and further enhance product retention
(150).
To further clarify and understand the unusual ligand binding and the mechanism of reaction
additional structures of mutant enzymes, enzyme inhibitor complexes and mutant enzyme
inhibitor complexes were studied. When a high resolution crystal structure (1.0 Å) of the
enzyme substrate complex was examined, a substrate sized internal cavity was found behind
flaps near the product binding site. The crystal structure (2.4 Å) of the enzyme complexed
with the inhibitor vanillate showed that the flaps were partly opened when compared to the
product bound enzyme.
An active site mutant enzyme G90A complexed with the product was examined at a
resolution of 2.0 Å. It was found that the presence of the additional methyl group in the
mutant enzyme resulted in the enlargement of the 4-HB binding pocket by about 1 Å.
However, all the 8-hydrogen bonds involved in product binding in the wild-type enzyme are
maintained. When the kinetic properties of the mutant enzyme were compared with the
wild-type enzyme it was found that the product inhibition increased by about 40%. The
wild-type enzyme had a Kp-value of 1.5 (±0.2) µM versus 0.9 (±0.1) µM for the mutant. The
increase in product inhibition in the mutant is attributed to the presence of the additional
methyl group acquired in the conversion of glycine to alanine. The Km values did not
change while the Kcat value of the mutant decreased to 0.9 (±04.)S−1 from 1.4 (±0.2)S−1.
When the G90A mutant enzyme was bound with the inhibitor vanillate, the structure at 1.9
Å showed two vanillate molecules. One of the vanillate molecules occupied the product site
normally occupied by 4-HB and the second molecule of vanillate occupied an adjacent site
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or cavity. The two sites were found to be connected by a tunnel that is open partly on both
ends. The product binding site was designated as the primary ligand site and the adjacent
site (additional site) where the second vanillate molecule binds was designated as the
secondary ligand site (150). On the basis of structural studies summarized above in
combination with molecular modeling, molecular dynamics and binding measurements with
inhibitors, a model has been proposed to account for catalytic, product binding, and product
release mechanisms.
It has been proposed that the enzyme operates by a two site or tunnel mechanism (150).
According to this mechanism, the enzyme contains bound 4-HB in the primary site
(designated as primary ligand site 1°). When the substrate binds to the second site
(designated as secondary ligand site 2°), it promotes the release of the product from the
primary site. As the product 4-HB is released from the primary site, the substrate chorismate
moves to the primary site. In the primary site the substrate is unstable and it is rapidly
converted to the products 4-HB and pyruvate. Since pyruvate is small, it exits rapidly from
the primary site while the 4-HB is retained in the bound state and the process is repeated in a
cyclic manner.
Prenylation of 4-hydroxybenzoate (Compound XX-------->XXI)
The prenylation of 4-hydroxybenzoate (XX) to 3-octaprenyl-4-hydroxybenzoate (XXI) is
carried out by the enzyme 4-hydroxybenzoate octaprenyltransferase encoded by the ubiA
gene. The enzyme is membrane bound and requires octaprenyl diphosphate and Mg2+ (175).
In addition to octaprenyl diphosphate, the enzyme could incorporate geranyl, farnesyl,
phytyl, or solanesyl diphosphate as a side chain precursor (35, 111). This lack of specificity
also extends to the aromatic substrate; thus, 4-aminobenzoate can replace 4-
hydroxybenzoate as a substrate (35). Recently, it has been shown that the enzyme accepts a
wide variety of benzoic acid derivatives as substrates. As already mentioned, replacing the
C-4 hydroxyl with an amino group did not affect reactivity. However, replacing the
hydroxyl with a methoxy group was not tolerated. Compounds substituted at C-5 with OH,
NH2, Cl, or CO-CH3 groups were used as substrates by the enzyme. Similarly, compounds
with hydroxyl groups at C-4, C-5 and C-6 or hydroxyl group at C-4, C-6 and methyl group
at C-5 were substrates (169).
The prenyl transfer reactions are electrophilic substitution reactions. The reaction
mechanism probably includes a carbocation (43); evidence for this proposal comes from
studies on the related enzyme dimethylallyltryptophan synthase (40).
Formation of 2-octaprenylphenol (Compound XXI -------->XXII)
The conversion of 3-octaprenyl-4-hydroxybenzoate (XXI) to 2-octaprenylphenol (XXII)
was demonstrated by Cox et al. (26). The enzyme responsible for this conversion was
named 3-octaprenyl-4-hydroxybenzoate decarboxylase. The presence of decarboxylase was
also observed by El Hachimi et al. (35). The enzyme activity was absent in ubiD mutants
(26).
Meganathan and Kwon Page 12













When cell extracts were prepared using a French press, centrifuged at 30,000×g, and the
supernatant further centrifuged at 150,000×g for 3 hrs, most of the activity remained in the
soluble fraction, establishing that the enzyme separated from the membrane. A 24-fold
purified preparation of the enzyme was obtained. The molecular weight of the enzyme was
reported to be Mr 340,000 (98). For optimal activity, the enzyme required Mn2+, washed
membranes or an extract of phospholipids, and an unidentified heat stable factor of
molecular weight less than 10,000. The reaction was strongly stimulated by dithiothreitol
and methanol. Since the substrate of the enzyme 3-octaprenyl-4-hydroxybenzoate is
membrane bound and the enzyme is stimulated by phospholipid, it has been suggested that
the enzyme normally functions in association with the cytoplasmic membrane in vivo (98).
A reaction mechanism has been suggested (6, 103).
A number of ubiD mutants studied form about 20% of the wild type levels of Q, indicating
that the mutants are leaky or there is an alternate enzyme for the reaction. However, the
significance of any alternate carboxy-lyase in wild type strains has been questioned (98).
An alternate 3-octaprenyl-4-hydroxybenzoate decarboxylase encoded by the ubiX gene has
been described in S. typhimurium which carries out the same reaction as the ubiD encoded
enzyme (61). An ubiX gene showing 70% homology to the S. typhimurium gene has been
identified in E. coli (118, 177). The orf′s encoding the two enzymes UbiD and UbiX have
been identified from E. coli (178). Recently, a report has appeared suggesting that both
UbiD and UbiX are required for the decarboxylation of 3-octaprenyl-4-hydroxybenzoate
particularly during logarithmic phase of growth (49).
It has been reported that several E. coli strains including the enterohaemorrhagic O157:H7
contain in addition to UbiX a second paralog designated as Pad1. The amino acid sequence
of this paralog was reported to have a 52% identity to UbiX and a slightly higher identity to
S. cerevisiae phenylacrylic acid decarboxylase Pad1. The exact biochemical role of E. coli
Pad remains to be determined (129).
Hydroxylation and methylation reactions
In the subsequent steps of the pathway, the 2-octaprenylphenol undergoes three
hydroxylation reactions alternating with three methylation reactions resulting in the
formation of ubiquinol (XXVIII) and then Q (I). For convenience, the hydroxylation
reactions are considered together and this will be followed by a description of the three
methylation reactions.
1. Hydroxylation reactions—Three flavin linked monooxygenases are involved in the
three hydroxylation reactions of the pathway with three hydroxyl groups being introduced at
positions C-6, C-4 and C-5 of the benzene nucleus, respectively. The three reactions are:
1. 2-octaprenylphenol (XXII) → 2-octaprenyl-6-hydroxyphenol (XXIII),
2. 2-octaprenyl-6-methoxyphenol (XXIV) → 2-octaprenyl-6-methoxy-1,4-
benzoquinol (XXV)
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3. 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol (XXVI) → 2-octaprenyl-3-
methyl-5-hydroxy-6-methoxy-1,4-benzoquinol (XXVII).
Mutants blocked in each of these hydroxylation reactions were isolated and designated as
ubiB, ubiH, and ubiF, respectively.
Consistent with their metabolic block, ubiB mutants accumulate 2-octaprenylphenol (XXII)
(26, 176). However, the predicted product of the UbiB reaction (XXIII) has never been
isolated and characterized and it may not occur as a free intermediate (2, 176).
As part of the genome project, when the sequence was annotated, ubiB was considered
identical to that of fre and luxG (28). In subsequent studies, an orf previously designated
yigR was identified as ubiB. An insertion mutant was isolated and was shown to accumulate
the expected intermediate in the pathway, 2-octaprenylphenol (compound XXII). As
mentioned above, the expected product of the reaction 2-octaprenyl-6-hydroxyphenol
(XXIII) could not be isolated (125).
Mutants blocked in the methylation of 2-octaprenyl-6-hydroxyphenol (XXIII) to 2-
octaprenyl-6-methoxyphenol (XXIV) have been isolated (ubiG::kan) (see methylation
reactions below). However, surprisingly, these mutants also failed to accumulate the
expected intermediate before the block 2-octaprenyl-6-hydroxyphenol (XXIII) thus
supporting the suggestion that it may not occur as a free intermediate (2, 176).
Mutants unable to convert (XXIV) to (XXV) have been isolated with the gene being
designated as ubiH (176). The ubiH gene is identical to the visB gene and confers a
photosensitive phenotype due to the accumulation of (XXIV) (115).
The final hydroxylation in Q biosynthesis is the conversion of (XXVI) to (XXVII) and
mutants blocked in the reaction were isolated and characterized. As expected, these mutants,
designated as ubiF, accumulated (XXVI) which was isolated and identified (174). The ubiF
gene was identified as orf391 and the product accumulated by insertion mutants in this orf
was found to be (XXVI) (92).
Under aerobic conditions, the origin of the oxygen atoms of Q was determined by 18O
labeling experiments. Cultures were grown on the oxidizable carbon source succinate, under
strictly aerobic conditions in a defined atmosphere of 18O2. The Q was isolated from these
cultures and subjected to mass spectral analysis. The spectrum showed several prominent
peaks with m/z values differing from that of normal Q by +6 establishing that 18O had been
incorporated. Further, it was demonstrated that the 18O was incorporated at positions 4, 5,
and 6 (2).
The nature of the hydroxylation reactions discussed above has been investigated. A hemA
mutant defective in the biosynthesis of cytochromes was able to convert 2-octaprenyl-[14C]
phenol to 14C-labeled Q-8, ruling out the involvement of the cytochrome P-450
monooxygenase system, and suggesting the involvement of flavin linked monooxygenases
in these reactions (75). A mechanism analogous to that proposed for the flavin dependent
tyrosine hydroxylase (166) has been suggested by Begley et al.(6).
Meganathan and Kwon Page 14













When grown anaerobically, with glycerol as a carbon source and fumarate as an electron
acceptor, E. coli forms considerable quantities of Q (50–70% of aerobically grown cells).
Mutants blocked in the various non-hydroxylating reactions of the pathway such as ubiA,
ubiD and ubiE, remain Q deficient under both aerobic and anaerobic conditions, establishing
that the same genes and enzymes participate under both aerobic and anaerobic conditions
(1).
In contrast, the three groups of mutants blocked in the three oxygenases discussed above,
ubiB, ubiH, and ubiF, were able to synthesize Q under anaerobic conditions providing
evidence that specific hydroxylases are involved in the anaerobic pathway (1). These
hydroxylases likely derive the hydroxyl groups from the solvent H2O similar to EntC and
MenF reactions discussed above.
2. Methylation reactions—Two methylations on O and one on C involved in the
pathway are:
1. 2-octaprenyl-6-hydroxyphenol (XXIII) → 2-octaprenyl-6-methoxyphenol (XXIV)
(i. e. O-methylation).
2. 2-octaprenyl-6-methoxy-1,4-benzoquinol (XXV) → 2-octaprenyl-3-methyl-6
methoxy-1,4-benzoquinol (XXVI) (i. e. C-methylation).
3. 2-octaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinol (OMHMB)
(XXVII) → ubiquinol (XXVIII) (i. e. O-methylation).
The methylation steps alternate with the three hydroxylations described above introducing
methyl groups at 6-OH, at the ring C-3 and the 5-OH group, respectively. The three methyl
groups are derived from methionine (66), with S-adenosylmethionine being the actual
methyl donor.
The C-methylase responsible for the methylation of ring C-3 is encoded by the ubiE gene.
Mutants blocked in the methylation accumulate the substrate of the enzyme, 2-octaprenyl-6-
methoxy-1,4-benzoquinol (XXV) (174). The UbiE enzyme is non-specific and carries out
the methylation of the menaquinone intermediate, DMK (III) → MK (II) in addition to its
role in the methylation of (XXV) → (XXVI) (95) (discussed in MK).
During the screening for mutants blocked in the O-methylation reactions, mutants blocked in
the methylation of 6-OH were not obtained. However, mutants blocked in the methylation of
the 5-OH were isolated, designated as ubiG and were shown to accumulate compound
(XXVII) which was isolated and characterized (154). Further, the ubiG mutants being leaky
formed about 10% of the wild type levels of Q (1). In subsequent studies, it was reported
that the O-methylase encoded by the ubiG gene is non-specific and that it carries out the
methylation of both 6-OH and 5-OH groups (62). This lack of specificity also extends to the
presence of other groups on the benzoquinone ring; the enzyme in addition, methylates 3, 4-
dihydroxy-5-hexaprenylbenzoquinol to 3-methoxy-4-hydroxy-5-hexaprenylbenzoquinol.
The reported leakiness of the ubiG mutant, mentioned above, likely allowed sufficient
intermediate (XXIII) to be methylated at the 6-OH resulting in the formation of (XXIV),
which was subsequently converted to (XXVII) and methylated at the 5-OH resulting in the
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formation of (XXVIII) and Q. A ubiG::kan mutant has been isolated. However,
surprisingly, this mutant failed to accumulate the expected intermediate before the block 2-
octaprenyl-6-hydroxyphenol (XXVIII). Two possible reasons have been advanced for the
failure to detect compound (XXVIII). Firstly, as mentioned above, compound (XXVIII)
may not occur as a free intermediate (2, 176). Secondly, it has been suggested that the
compound may be highly reactive due to the presence of the catechol moiety and hence
degraded (62).
Organization of Q biosynthetic enzymes into a complex
As discussed above, not all the enzymes involved in Q biosynthesis have been studied in cell
free extracts. Among the enzymes studied, chorismate pyruvate-lyase (UbiC) is a
cytoplasmic enzyme, while 4-hydroxybenzoate octaprenyltransferase (UbiD) is firmly
membrane bound. Two other enzymes that have been studied, 3-octaprenyl-4-
hydroxybenzoate carboxy-lyase and 2-octaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-
benzoquinol methyltransferase, are considered to be normally associated with the membrane
(97, 98). The association of enzymes with membrane is supported by the isolation of a 2-
octaprenyl [U-14C] phenol (XXII) charged enzyme complex of molecular mass Mr of 2×106
containing at least 12 proteins ranging from 40,000 to 80,000 Mr from cells grown
anaerobically on glycerol/fumarate medium in the presence of 4-hydroxy[U-14C] benzoate.
When this complex was incubated with S-adenosylmethionine, NADH, NADPH, Mg2+, and
a cytoplasmic enzyme of molecular weight of about 20,000 (probably a methyltransferase)
(77) in the presence of oxygen, all of the 14C-labelled phenol was converted to Q (76). This
complex, therefore, contains the oxygen dependent Q-8 biosynthetic apparatus. In
anaerobically grown cells, this apparatus which is charged with 2-octaprenylphenol may be
kept in a standby position. When oxygen becomes available, Q-8 biosynthesis can be
effectively turned on (76, 77). Since this complex was isolated without detergent treatment,
it was thought that it had broken from the membrane as a distinct and native domain. This
complex contains in addition to a high level of 2-octaprenylphenol and low levels of Q,
phospholipid, and other membrane proteins (76, 77).
Based on studies with a thiol-sensitive mutant (IS16), it was reported that there is genetic
evidence for interaction between UbiX and UbiG proteins (50). The IS16 mutant had point
mutations resulting in change of a single amino acid in UbiX (S98R) and UbiG (L132Q)
when compared to the sequence of the same two proteins in E. coli K12. Complementation
of this mutant with either ubiX from E. coli K12 strain (ubiX K12) or ubiG K12 restored the
wild-type phenotype. In conntrast, while an ubiG insertion mutant was rescued by
complementation by ubiG K12 it was not rescued by ubiX K12 (50). Rescue of Q deficient
phenotypes can be achieved by levels of Q that are significantly lower than that present in
the wild-type strains (50). These studies were cited as providing supporting evidence for the
polypeptide complex described by Knoll (77) discussed above.
Regulation of Q biosynthetic genes
It is known that the quinone composition of E. coli is influenced by the availability of
oxygen. Cells grown under vigorous aeration contain 2 to 3-fold higher concentrations of Q
compared to DMK and MK. Under anaerobic conditions, the MK and DMK concentration
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increases 2 to 3-fold while the concentration of Q decreases (12, 152). The mechanism of
this regulation is not completely understood. Shestopalov et al. (145) have shown that
chloramphenicol had no effect on these changes, suggesting post-translational regulation of
quinone levels. Further, these authors have shown that mutations in the regulatory systems
of Fnr and Arc had no effect on the quinone pool. Suzuki et al. (156) studied the regulation
of the ubiA gene using plasmid borne lacZ fusions and showed that the gene is catabolite
repressed by glucose. A similar study on plasmid borne ubiG gene also showed glucose
catabolite repression (44). SØballe and Poole (151) studied the transcriptional regulation of
ubiC-lacZ in a monolysogen and showed that the expression was higher aerobically than
anaerobically. It was further reported that glucose repressed expression while anaerobic
growth in the presence of alternate electron acceptors, nitrate and fumarate did not affect
expression. Further it was shown that ubiC was negatively regulated by transcriptional
regulators Fnr and IHF (151).
In a recent study, the expression of the operon fusions ubiC’-lacZ+, ubiCA’-lacZ+, and
ubiA’-lacZ+ were studied. In glycerol media under aerobic conditions the highest level of
expression was observed with the operon fusion ubiC’-lacZ+. Compared with the ubiC’-
lacZ+, the ubiCA’-lacZ+ operon fusion showed 26% of the activity while the ubiA’-lacZ+
operon fusion had an activity of 1%. Thus, the ubiC gene is regulated by the upstream
promoter while the ubiA gene lacks its own promoter (90). The effect of fermentable and
oxidizable carbon sources on the expression of ubiC’-lacZ+ was determined. The expression
was low in the case of fermentable carbon source glucose; increasing glucose concentration
resulted in increased repression. In the presence of oxidizable carbon sources the expression
increased 2- to 3-fold. In both fermentable and oxidizable carbon sources, supplementation
of the medium with casamino acids resulted in decrease in expression. Aerobically,
deficiency in both Q and MK or MK alone resulted in a 2-fold increase in expression
compared with wild-type cells. In the strain carrying the arcA mutation, under anaerobic
conditions the expression was from 25% to 50% higher than the anaerobically grown wild-
type strain, while in the fnr mutant the activities did not change (90). The lack of regulation
by FNR is in agreement with the absence of binding site (139). In the case of the narXL
mutant, the activity increased 50% anaerobically and 137% in the presence of NO3− In the
presence of other electron acceptors, O2, fumarate, and TMAO, the activities were from
70% to 90% higher than that of the wild-type (90).
The expressions of the two genes involved in the decarboxylation of 3-octaprenyl-4-
hydroxybenzoate, ubiD and ubiX were studied using LacZ operon fusions. During aerobic
growth the expression of both genes depended on the carbon source:
succinate>glycerol>glucose. Mutations in fnr, arcA or hemA increased the expressions of
both genes. During anaerobic growth in LB medium glucose strongly repressed the
expression of ubiD but not ubiX (178).
Consequences of mutations in ubi genes
Certain pleotrophic properties which will be of value in isolating and/or characterizing
mutants are described here. As described above, ubi mutants were isolated by their inability
to utilize succinate or other reduced compounds as carbon sources.
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Hypersensitivity to thiols such as dithiothreitol (DTT), 2-mercaptoethanol and 1-
thioglycerol was demonstrated in ubiX and ubiD mutants (177). Subsequently, it was shown
that a ubiCA insertion mutant also exhibited this property (153). Thiol sensitivity is likely a
common property of all Q deficient strains since a respiratory chain is essential for the
maintenance of the disulfide bond forming system (78, 79).
An E. coli mutant resistant to the antibiotic and antitumor agent phleomycin was isolated.
The mutant was also found to be resistant to bleomycin and unable to grow on succinate as
the sole source of carbon and resistant to the lethal effects of heating at 52°C. The suc−
phenotype and mapping data led to the conclusion that the mutant was defective in the ubiF
gene. To confirm the observed properties, known ubiA, ubiD and ubiF mutants were
compared with the newly isolated mutants. It was found that they also exhibited these
properties (24). Recently, an ubiCA mutant was shown to exhibit the pleotrophic phenotype,
being resistant to heat, linolenic acid and phleomycin. In addition, it has been shown that Q
is involved in superoxide scavenging, and in protection against oxidative stress mediated by
CuSO4 or H2O2 (153).
A mutant showing partial resistance to streptomycin was found to be defective in the ubiF
gene. Membranes of this strain accumulated 2-octaprenyl-3-methyl-6-methoxy-1,4
benzoquinol (XXVI) but not Q. A previously characterized ubiF mutant was found to show
reduced uptake of gentamycin. At present, there is no evidence implicating Q in
aminoglycoside antibiotic uptake and these observations are attributed to the general
impairment of respiratory capacity (114).
Mutations in the Q biosynthetic pathway (ubiD, ubiB, and ubiG) led to the lack of flagellar
synthesis and motility (5, 58). An ubiA men+ strain was motile anaerobically and nonmotile
aerobically, while mutants blocked in Q and MK were found to be nonmobile under both
aerobic and anaerobic conditions. Thus, it appears that a functional electron transport system
is essential for motility and flagellar synthesis.
Mutants lacking Q, MK or both have been isolated and the role of quinones in electron
transport to oxygen and nitrate has been studied (164).
Functions of isoprenoid quinones MK and Q
The roles of MK in the anaerobic respiratory chains and Q in the aerobic respiratory chains
are well established. For details on the role of the quinones other reviews and chapters in
this series should be consulted (32, 41, 51, 52, 64, 73, 123, 124, 131, 152). EcoSal Chapter
The Aerobic and Anaerobic Respiratory Chain of Escherichia coli and Salmonella enterica:
Enzymes and Energetics covers the aerobic and anaerobic metabolism and respiratory
chains.
Biosynthesis of Isoprenoid side chain of MK and Q
E. coli and other Gram negative bacteria synthesize the isopentenyl diphosphate (IPP) and
dimethylallyl diphosphate (DMAPP) by the mevalonate-independent pathway also known as
non-mevalonate pathway (other names are deoxyxylulose phosphate or methylerythritol
phosphate pathway) The IPP condenses with DMAPP and the prenyl chain is elongated to
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the 40-carbon octaprenyl diphosphate (OPP). The details of side chain biosynthesis are
beyond the scope of this chapter. A number of reviews are available on the topic (21, 34, 37,
38, 63, 87, 103, 107, 135–138, 149, 158).
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Structures of major quinones found in E. coli. In the structure of MK, the A ring and B ring
of the naphthoquinone are shown.
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Formation of Q and MK.
Meganathan and Kwon Page 30














Primary biosynthetic precursors of menaquinones.
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Menaquinone biosynthetic pathway. Each compound in the pathway is identified by its
abbreviation and a Roman numeral. CHA, chorismate; ICHA, isochorismate; SS-TPP,
succinic semialdehyde-TPP, R1 = pyrimidine component of TPP, R2 = CH3, R3 = CH2CH2
OP2O63−; SEPHCHC, 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate;
SHCHC, 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate; OSB, o-
succinylbenzoate; OSB-CoA; o-succinylbenzoyl-CoA; DHNA-CoA, 1,4-dihydroxy-2-
napththoyl-CoA; DHNA, 1,4-dihydroxy-2-napththoate; DMK-8, demethylmenaquinone
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(may be initially formed as a quinol). MK-8, menaquinone; SAM, S-adenosylmethionine;
SAH, S-adenosylhomocysteine. The genes encoding the enzymes are shown for each
reaction followed by their location on the chromosome in min. The gene encoding the
thioesterase for the conversion of DHNA-CoA (compound XI) to DHNA (compound XII)
remains to be identified and is shown as men? ?.
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Proposed mechanism of succinic semialdehyde-TPP anion formation and SHCHC (VIII)
synthesis. Only the thiazole ring of the TPP is shown since it is the active site of the
molecule. For R1, R2, and R3 see the legend to Fig. 4. The reactions from (XIII) to
SEPHCHC (VII) are carried out by MenD and the conversion of SEPHCHC (VII) ----->
SHCHC (VIII) is by MenH.
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Proposed mechanism of formation of acyl adenylate of OSB (XVIII) and its subsequent
conversion to OSB-CoA (X). The conversion of OSB-CoA (X) to spirodilactone of OSB
(XIX) is non-enzymatic.
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Ubiquinone biosynthetic pathway. Each compound in the pathway is identified by a Roman
numeral. Under anaerobic conditions, there are alternate hydroxylases for the three enzymes
incorporating molecular oxygen (UbiB, UbiH, and UbiF). It should be noted that in
compound (XXI), the chemical numbering system locates the prenyl side chain at the C-3
carbon; in compound (XXII) and subsequent intermediates, the prenyl side chain is assigned
to C-2. Compounds (XXV), (XXVI), and (XXVII), are drawn in the quinol form. Some
authors draw these structures in the quinone form. For other abbreviations see legend to Fig.
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4. The chemical names for the intermediates of the pathway are as follows: (IV),
chorismate; (XX), 4-hydroxybenzoate; (XXI), 3-octaprenyl-4-hydroxybenzoate; (XXII), 2-
octaprenylphenol; (XXIII), 2-octaprenyl-6-hydroxyphenol; (XIV), 2-octaprenyl-6-
methoxyphenol; (XXV), 2-octaprenyl-6-methoxy-1,4-benzoquinol; (XXVI), 2-octaprenyl-3-
methyl-6 methoxy-1,4-benzoquinol; (XXVII), 2-octaprenyl-3-methyl-5-hydroxy-6-
methoxy-1,4-benzoquinol; (XXVIII), ubiquinol; (I), Q, ubiquinone. The conversion of
(XXVIII) to (I) is thought to be non-enzymatic.
Meganathan and Kwon Page 37
Ecosal Plus. Author manuscript; available in PMC 2014 September 23.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
